{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:36:30Z","timestamp":1794026190774,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Expression of neuronal elements has been identified in various glial tumors, and glioblastomas (GBMs) with neuronal differentiation patterns have reportedly been associated with longer survival. However, the neuronal class III \u03b2-tubulin has been linked to increasing malignancy in astrocytomas. Thus, the significance of neuronal markers in gliomas is not established.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The expressions of class III \u03b2-tubulin, neurofilament protein (NFP), microtubule-associated protein 2 (MAP2) and neuron-specific enolase (NSE) were investigated in five GBM cell lines and two GBM biopsies with immunocytochemistry and Western blot. Moreover, the expression levels were quantified by real-time qPCR under different culture conditions. Following NSE siRNA treatment we used Electric cell-substrate impedance sensing (ECIS) to monitor cell growth and migration and MTS assays to study viability after irradiation and temozolomide treatment. Finally, we quantitated NSE expression in a series of human glioma biopsies with immunohistochemistry using a morphometry software, and collected survival data for the corresponding patients. The biopsies were then grouped according to expression in two halves which were compared by survival analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Immunocytochemistry and Western blotting showed that all markers except NFP were expressed both in GBM cell lines and biopsies. Notably, qPCR demonstrated that NSE was upregulated in cellular stress conditions, such as serum-starvation and hypoxia, while we found no uniform pattern for the other markers. NSE knockdown reduced the migration of glioma cells, sensitized them to hypoxia, radio- and chemotherapy. Furthermore, we found that GBM patients in the group with the highest NSE expression lived significantly shorter than patients in the low-expression group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Neuronal markers are aberrantly expressed in human GBMs, and NSE is consistently upregulated in different cellular stress conditions. Knockdown of NSE reduces the migration of GBM cells and sensitizes them to hypoxia, radiotherapy and chemotherapy. In addition, GBM patients with high NSE expression had significantly shorter survival than patients with low NSE expression. Collectively, these data suggest a role for NSE in the adaption to cellular stress, such as during treatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2407-11-524","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T19:32:44Z","timestamp":1324409564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide"],"prefix":"10.1186","volume":"11","author":[{"given":"Tao","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Ove","family":"Skaftnesmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Leiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Sleire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per \u00d8yvind","family":"Enger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,20]]},"reference":[{"issue":"4-6","key":"2998_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0165-5728(85)80063-1","volume":"8","author":"LF Eng","year":"1985","unstructured":"Eng LF: Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol. 1985, 8 (4-6): 203-214.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2998_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1227\/00006123-199501000-00001","volume":"36","author":"ME Linskey","year":"1995","unstructured":"Linskey ME, Gilbert MR: Glial differentiation: a review with implications for new directions in neuro-oncology. Neurosurgery. 1995, 36 (1): 1-21. 10.1227\/00006123-199501000-00001. discussion 21-22","journal-title":"Neurosurgery"},{"issue":"3","key":"2998_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","volume":"9","author":"HS Phillips","year":"2006","unstructured":"Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et al: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006, 9 (3): 157-173. 10.1016\/j.ccr.2006.02.019.","journal-title":"Cancer Cell"},{"issue":"21","key":"2998_CR4","doi-asserted-by":"publisher","first-page":"8255","DOI":"10.1158\/0008-5472.CAN-10-1592","volume":"70","author":"L Prestegarden","year":"2010","unstructured":"Prestegarden L, Enger PO: Cancer stem cells in the central nervous system--a critical review. Cancer Res. 2010, 70 (21): 8255-8258. 10.1158\/0008-5472.CAN-10-1592.","journal-title":"Cancer Res"},{"issue":"5","key":"2998_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2990.2010.01078.x","volume":"36","author":"K Donev","year":"2010","unstructured":"Donev K, Scheithauer BW, Rodriguez FJ, Jenkins S: Expression of diagnostic neuronal markers and outcome in glioblastoma. Neuropathol Appl Neurobiol. 2010, 36 (5): 411-421. 10.1111\/j.1365-2990.2010.01078.x.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"2998_CR6","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1227\/01.NEU.0000143033.36582.40","volume":"55","author":"P Varlet","year":"2004","unstructured":"Varlet P, Soni D, Miquel C, Roux FX, Meder JF, Chneiweiss H, Daumas-Duport C: New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases. Neurosurgery. 2004, 55 (6): 1377-1391. discussion 1391-1372","journal-title":"Neurosurgery"},{"issue":"11","key":"2998_CR7","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1158\/0008-5472.CAN-09-3904","volume":"70","author":"L Prestegarden","year":"2010","unstructured":"Prestegarden L, Svendsen A, Wang J, Sleire L, Skaftnesmo KO, Bjerkvig R, Yan T, Askland L, Persson A, Sakariassen P, et al: Glioma cell populations grouped by different cell type markers drive brain tumor growth. Cancer Res. 2010, 70 (11): 4274-4279. 10.1158\/0008-5472.CAN-09-3904.","journal-title":"Cancer Res"},{"issue":"5","key":"2998_CR8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5858\/2001-125-0613-ALOTNC","volume":"125","author":"CD Katsetos","year":"2001","unstructured":"Katsetos CD, Del Valle L, Geddes JF, Assimakopoulou M, Legido A, Boyd JC, Balin B, Parikh NA, Maraziotis T, de Chadarevian JP, et al: Aberrant localization of the neuronal class III beta-tubulin in astrocytomas. Arch Pathol Lab Med. 2001, 125 (5): 613-624.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2998_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1054\/jocn.2001.1055","volume":"9","author":"SB Wharton","year":"2002","unstructured":"Wharton SB, Chan KK, Whittle IR: Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas. J Clin Neurosci. 2002, 9 (2): 165-169. 10.1054\/jocn.2001.1055.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"2998_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/00000478-200204000-00010","volume":"26","author":"C Giannini","year":"2002","unstructured":"Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR: Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol. 2002, 26 (4): 479-485. 10.1097\/00000478-200204000-00010.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2998_CR11","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/jnen\/61.11.947","volume":"61","author":"A Perry","year":"2002","unstructured":"Perry A, Scheithauer BW, Macaulay RJ, Raffel C, Roth KA, Kros JM: Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol. 2002, 61 (11): 947-955.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"2998_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00401-006-0153-x","volume":"113","author":"FJ Rodriguez","year":"2007","unstructured":"Rodriguez FJ, Scheithauer BW, Robbins PD, Burger PC, Hessler RB, Perry A, Abell-Aleff PC, Mierau GW: Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum. Acta Neuropathol. 2007, 113 (3): 313-324. 10.1007\/s00401-006-0153-x.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2998_CR13","first-page":"883","volume":"142","author":"T Tlhyama","year":"1993","unstructured":"Tlhyama T, Lee VM, Trojanowski JQ: Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines. Am J Pathol. 1993, 142 (3): 883-892.","journal-title":"Am J Pathol"},{"issue":"4","key":"2998_CR14","first-page":"797","volume":"8","author":"LA Akslen","year":"1988","unstructured":"Akslen LA, Andersen KJ, Bjerkvig R: Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res. 1988, 8 (4): 797-803.","journal-title":"Anticancer Res"},{"issue":"3","key":"2998_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3171\/jns.1990.72.3.0463","volume":"72","author":"R Bjerkvig","year":"1990","unstructured":"Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO: Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg. 1990, 72 (3): 463-475. 10.3171\/jns.1990.72.3.0463.","journal-title":"J Neurosurg"},{"issue":"44","key":"2998_CR16","doi-asserted-by":"publisher","first-page":"16466","DOI":"10.1073\/pnas.0607668103","volume":"103","author":"PO Sakariassen","year":"2006","unstructured":"Sakariassen PO, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, et al: Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci USA. 2006, 103 (44): 16466-16471. 10.1073\/pnas.0607668103.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2998_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0300-483X(97)00151-0","volume":"124","author":"G Malich","year":"1997","unstructured":"Malich G, Markovic B, Winder C: The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology. 1997, 124 (3): 179-192. 10.1016\/S0300-483X(97)00151-0.","journal-title":"Toxicology"},{"issue":"3","key":"2998_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcp.21870","volume":"221","author":"CD Katsetos","year":"2009","unstructured":"Katsetos CD, Dr\u00e1berov\u00e1 E, Legido A, Dumontet C, Dr\u00e1ber P: Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin. J Cell Physiol. 2009, 221 (3): 505-513. 10.1002\/jcp.21870.","journal-title":"J Cell Physiol"},{"issue":"1","key":"2998_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0006-8993(80)91168-3","volume":"190","author":"PJ Marangos","year":"1980","unstructured":"Marangos PJ, Schmechel DE, Parma AM, Goodwin FK: Developmental profile of neuron-specific (NSE) and non-neuronal (NNE) enolase. Brain Res. 1980, 190 (1): 185-193. 10.1016\/0006-8993(80)91168-3.","journal-title":"Brain Res"},{"issue":"3","key":"2998_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/cne.903270304","volume":"327","author":"M Watanabe","year":"1993","unstructured":"Watanabe M, Nagamine T, Sakimura K, Takahashi Y, Kondo H: Developmental study of the gene expression for alpha and gamma subunits of enolase in the rat brain by in situ hybridization histochemistry. J Comp Neurol. 1993, 327 (3): 350-358. 10.1002\/cne.903270304.","journal-title":"J Comp Neurol"},{"issue":"11","key":"2998_CR21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ: Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004, 4 (11): 891-899. 10.1038\/nrc1478.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2998_CR22","first-page":"536","volume":"108","author":"SA Vinores","year":"1984","unstructured":"Vinores SA, Bonnin JM, Rubinstein LJ, Marangos PJ: Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues. Arch Pathol Lab Med. 1984, 108 (7): 536-540.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2998_CR23","first-page":"2595","volume":"44","author":"SA Vinores","year":"1984","unstructured":"Vinores SA, Marangos PJ, Bonnin JM, Rubinstein LJ: Immunoradiometric and immunohistochemical demonstration of neuron-specific enolase in experimental rat gliomas. Cancer Res. 1984, 44 (6): 2595-2599.","journal-title":"Cancer Res"},{"issue":"3","key":"2998_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0168-0102(94)00849-B","volume":"21","author":"T Hattori","year":"1995","unstructured":"Hattori T, Takei N, Mizuno Y, Kato K, Kohsaka S: Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain. Neurosci Res. 1995, 21 (3): 191-198. 10.1016\/0168-0102(94)00849-B.","journal-title":"Neurosci Res"},{"issue":"2","key":"2998_CR25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF03160188","volume":"4","author":"M Kuramitsu","year":"1986","unstructured":"Kuramitsu M, Sawa H, Takeshita I, Iwaki T, Kato K: Neuron-specific gamma-enolase derived from human glioma. Neurochem Pathol. 1986, 4 (2): 89-105.","journal-title":"Neurochem Pathol"},{"issue":"10","key":"2998_CR26","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1517\/13543784.17.10.1533","volume":"17","author":"R Scatena","year":"2008","unstructured":"Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B: Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs. 2008, 17 (10): 1533-1545. 10.1517\/13543784.17.10.1533.","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"2998_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2174\/156800909788166637","volume":"9","author":"V Amberger-Murphy","year":"2009","unstructured":"Amberger-Murphy V: Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets. 2009, 9 (3): 381-390. 10.2174\/156800909788166637.","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"2998_CR28","first-page":"725","volume":"33","author":"T Hamaguchi","year":"2008","unstructured":"Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, et al: Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol. 2008, 33 (4): 725-731.","journal-title":"Int J Oncol"},{"issue":"9","key":"2998_CR29","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.ejca.2010.03.018","volume":"46","author":"ST Tsai","year":"2010","unstructured":"Tsai ST, Chien IH, Shen WH, Kuo YZ, Jin YT, Wong TY, Hsiao JR, Wang HP, Shih NY, Wu LW: ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. Eur J Cancer. 2010, 46 (9): 1712-1723. 10.1016\/j.ejca.2010.03.018.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2998_CR30","first-page":"93","volume":"13","author":"M Petrovic","year":"2008","unstructured":"Petrovic M, Tomic I, Plavec G, Ilic S, Ilic N, Baskic D: Neuron specific enolase tissue expression as a prognostic factor in advanced non small cell lung cancer. J BUON. 2008, 13 (1): 93-96.","journal-title":"J BUON"},{"issue":"10","key":"2998_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1053\/S0046-8177(03)00411-8","volume":"34","author":"N Makretsov","year":"2003","unstructured":"Makretsov N, Gilks CB, Coldman AJ, Hayes M, Huntsman D: Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol. 2003, 34 (10): 1001-1008. 10.1053\/S0046-8177(03)00411-8.","journal-title":"Hum Pathol"},{"issue":"5","key":"2998_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/bjc.1994.179","volume":"69","author":"A Berner","year":"1994","unstructured":"Berner A, Harvei S, Tretli S, Fossa SD, Nesland JM: Prostatic carcinoma: a multivariate analysis of prognostic factors. Br J Cancer. 1994, 69 (5): 924-930. 10.1038\/bjc.1994.179.","journal-title":"Br J Cancer"},{"issue":"6","key":"2998_CR33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1464-410X.1995.tb07385.x","volume":"75","author":"FJ Allen","year":"1995","unstructured":"Allen FJ, Van Velden DJ, Heyns CF: Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?. Br J Urol. 1995, 75 (6): 751-754. 10.1111\/j.1464-410X.1995.tb07385.x.","journal-title":"Br J Urol"},{"issue":"4","key":"2998_CR34","first-page":"2511","volume":"24","author":"MJ Vos","year":"2004","unstructured":"Vos MJ, Postma TJ, Martens F, Uitdehaag BM, Blankenstein MA, Vandertop WP, Slotman BJ, Heimans JJ: Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot study. Anticancer Res. 2004, 24 (4): 2511-2514.","journal-title":"Anticancer Res"},{"key":"2998_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6890-11-4","volume":"11","author":"MS Ayoub","year":"2011","unstructured":"Ayoub MS, Baghdadi HM, El-Kholy M: Immunohistochemical detection of laminin-1 and Ki-67 in radicular cysts and keratocystic odontogenic tumors. BMC Clin Pathol. 2011, 11: 4-10.1186\/1472-6890-11-4.","journal-title":"BMC Clin Pathol"},{"issue":"3","key":"2998_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcp.21870","volume":"221","author":"CD Katsetos","year":"2009","unstructured":"Katsetos CD, Draberova E, Legido A, Dumontet C, Draber P: Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin. J Cell Physiol. 2009, 221 (3): 505-513. 10.1002\/jcp.21870.","journal-title":"J Cell Physiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-524\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T23:56:24Z","timestamp":1686527784000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2998"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-524","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"9 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"524"}}